Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
WASHINGTON, USA, March 13, 2020 (GLOBE NEWSWIRE) -- Das Sabin Vaccine Institute (Sabin) gibt den Erhalt einer Drei-Jahres-Förderung in Höhe von 10,4 Millionen US-Dollar für die Stärkung der...
-
ワシントン発, March 13, 2020 (GLOBE NEWSWIRE) -- サビン･ワクチン･インスティテュート (Sabin Vaccine Institute、略称「サビン」) は本日、同組織がワクチン受容を促進するため、3年間で1,040万ドル (約10億5,800万円) の助成金を受け取ったことを発表した。2019年、世界保健機関 (WHO)...
-
WASHINGTON, March 13, 2020 (GLOBE NEWSWIRE) -- O Sabin Vaccine Institute (Sabin) anunciou hoje que recebeu uma doação de três anos no valor de US $ 10,4 milhões para solidificar a aceitação da...
-
WASHINGTON, March 13, 2020 (GLOBE NEWSWIRE) -- El Sabin Vaccine Institute (Sabin), anunció hoy que recibió un subsidio de tres años por un valor de $10,4 millones para solidificar la aceptación de...
-
WASHINGTON, March 12, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced it has received a three-year grant valued at $10.4 million to strengthen vaccine acceptance. In...
-
Washington, DC, March 05, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has partnered with the Vaccine Research Center (VRC), National Institute of Allergy and...
-
Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its...
-
WASHINGTON, Oct. 01, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical...
-
Washington, D.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees. Joining the Board are Drs....
-
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines LONDON and WASHINGTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- GSK and the Sabin Vaccine...